Fierce Biotech July 10, 2024
Flagship Pioneering has brought in $2.6 billion via its eighth venture fund, with a further $1 billion coming from an array of side funds, as the venture creation firm hunts for even more Big Pharma partnerships.
While still eye-raising, the $2.6 billion for Flagship VIII falls below the $3 billion that Flagship had aimed for when plans for the fund were filed with the Securities and Exchange Commission in November 2023. Still, when combined with side funds from an array of big-name partnerships, the firm has in fact raised its capital base by $3.6 billion, according to the July 10 release.
Those partnerships include committing $50 million in July 2023 to a 10-program pact with Pfizer. Last month, the two...
Today's Sponsors
Today's Sponsor